Pediatric Drugs

, Volume 21, Issue 3, pp 195–202 | Cite as

Comparison of Quality of Life, Depression, Anxiety, Suicide, Social Anxiety and Obsessive–Compulsive Symptoms Between Adolescents with Acne Receiving Isotretinoin and Antibiotics: A Prospective, Non-randomised, Open-Label Study

  • Yakup Erdoğan
  • İjlal ErturanEmail author
  • Evrim Aktepe
  • Abdulbaki Akyıldız
Original Research Article



The effects of isotretinoin on suicide, social anxiety and obsessive–compulsive symptoms in adolescents with acne have not been sufficiently investigated.


This study aimed to evaluate the quality of life, depression, anxiety, suicide, social anxiety, and obsessive–compulsive symptoms of adolescents receiving systemic isotretinoin and antibiotic treatments at baseline and at 3 months.


The study included a total of 102 adolescents using isotretinoin (n = 60) and antibiotics (n = 42). The Acne Quality of Life Scale (AQLS), Hospital Anxiety and Depression Scale (HADS), Suicide Probability Scale (SPS), Liebowitz Social Anxiety Scale (LSAS), and Maudsley Obsessive–Compulsive Question List (MOCQL) were administered to both groups at baseline and at 3 months. In order to exclude patients with comorbid psychiatric disorders, the patients were evaluated at the beginning of the study with the Schedule for Affective Disorders and Schizophrenia for School-Age Children–Present and Lifetime Version (K-SADS-PL).


There were no significant differences in the mean age, gender distribution, educational level, and family history of mental illness between the two groups. There were significant decreases in the Global Acne Grading System scores, visual analogue scale scores, AQLS scores, total and subscale scores of LSAS, and total and subscale scores of MOCQL at 3 months compared with baseline in both groups. However, there were no significant changes in the total and subscale scores of HADS and total and subscale scores of SPS at 3 months compared with baseline in both groups.


We found that neither isotretinoin nor antibiotic treatment affected the levels of depression, anxiety, and suicide in acne patients. Moreover, both isotretinoin and antibiotic treatment were shown to improve the quality of life, social anxiety, and obsessive–compulsive symptoms in acne patients. However, clinicians should be careful about psychiatric side effects in patients using isotretinoin. Further studies with a larger number of cases and with a longer follow-up period are needed to investigate the complex effects of isotretinoin on the central nervous system.


Compliance with Ethical Standards

Ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.


This study did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Conflict of interest

The authors, Yakup Erdoğan, İjlal Erturan, Evrim Aktepe, and Abdulbaki Akyıldız, declare that they have no conflict of interest.


  1. 1.
    Ozturk A, Deveci E, Bagcioglu E, Atalay F, Serdar Z. Anxiety, depression, social phobia, and quality of life in Turkish patients with acne and their relationships with the severity of acne. Turk J Med Sci. 2013;43:660–6.CrossRefGoogle Scholar
  2. 2.
    Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol. 1997;137:246–50.CrossRefGoogle Scholar
  3. 3.
    Azoulay L, Blais L, Koren G, LeLorier J, Berard A. Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry. 2008;69:526–32.CrossRefGoogle Scholar
  4. 4.
    Friedman T, Wohl Y, Knobler HY, et al. Increased use of mental health services related to Isotretinoin treatment: a 5-year analysis. Eur Neuropsychopharmacol. 2006;16:413–6.CrossRefGoogle Scholar
  5. 5.
    Yesilova Y, Bez Y, Ari M, Turan E. Effects of isotretinoin on social anxiety and quality of life in patients with acne vulgaris: a prospective trial. Acta Dermatovenerol Croat. 2012;20:80–3.Google Scholar
  6. 6.
    Karadag AS, Bilgili SG, Selvi Y, et al. Effects of isotretinoin treatment on general psychiatric symptoms, quality of life and social phobia in acne vulgaris patients. J Eur Acad Dermatol Venereol. 2013;27:260–1.CrossRefGoogle Scholar
  7. 7.
    Yesilova Y, Bez Y, Ari M, Kaya MC, Alpak G. Effects of isotretinoin on obsessive compulsive symptoms, depression, and anxiety in patients with acne vulgaris. J Dermatol Treat. 2012;23(4):268–71.CrossRefGoogle Scholar
  8. 8.
    Gupta MA, Schork NJ, Ellis CN. Psychosocial correlates of the treatment of photodamaged skin with topical retinoic acid: a prospective controlled study. J Am Acad Dermatol. 1994;30:969–72.CrossRefGoogle Scholar
  9. 9.
    Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol. 1997;36(6):416–8.CrossRefGoogle Scholar
  10. 10.
    Sadick NS, Laver Z, Laver L. Treatment of mild-to-moderate acne vulgaris using a combined light and heat energy device: home-use clinical study. J Cosmet Laser Ther. 2010;12(6):276–83.CrossRefGoogle Scholar
  11. 11.
    Gupta MA, Johnson AM, Gupta AK. The development of an Acne Quality of Life Scale: reliability, validity, and relation to subjective acne severity in mild to moderate acne vulgaris. Acta Dermato-Venereol. 1998;78:451–6.CrossRefGoogle Scholar
  12. 12.
    Demircay Z, Senol A, Seckin D, Demir F. Reliability of Turkish version of Acne Quality of Life Scale in patients with acne vulgaris. Turkderm Arch Turk Dermatol Venerol. 2006;40:94–7.Google Scholar
  13. 13.
    Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–70.CrossRefGoogle Scholar
  14. 14.
    Aydemir O, Guvenir T, Kuey L, Kultur S. Validity and reliability study of the Hospital Anxiety and Depression Scale Turkish Form. Turk J Psychiatr. 1997;8:280–7.Google Scholar
  15. 15.
    Cull JG, Gill WS. The Suicide Probability Scale. Los Angeles: Western Psychological Services; 1988.Google Scholar
  16. 16.
    Atli Z, Eskin M, Dereboy C. The validity and reliability of Suicidal Probability Scale in Clinical Sample. J Clin Psychiatry. 2009;12:111–24.Google Scholar
  17. 17.
    Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry. 1987;22:141–73.CrossRefGoogle Scholar
  18. 18.
    Soykan C, Ozgüven HD, Gencoz T. Liebowitz Social Anxiety Scale: the Turkish version. Psychol Rep. 2003;93:1059–69.CrossRefGoogle Scholar
  19. 19.
    Hodgson RJ, Rachman S. Obsessional-compulsive complaints. Behav Res Ther. 1977;15:389–95.CrossRefGoogle Scholar
  20. 20.
    Erol N, Savasir I. Maudsley obsessive compulsive question list. In: 24th national psychiatry and neurological sciences congress scientific program abstracts book 1988, pp 104–114.Google Scholar
  21. 21.
    Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980–8.CrossRefGoogle Scholar
  22. 22.
    Gokler B, Unal F, Pehlivanturk B, Kultur EC, Akdemir D, Taner Y. Reliability and validity of schedule for affective disorders and schizophrenia for school age children-present and lifetime version-Turkish Version (K-SADS-PL-T). Turk J Child Adolesc Ment Health. 2004;11:109–16.Google Scholar
  23. 23.
    Marron SE, Tomas-Aragones L, Boira S. Anxiety, depression, quality of life and patient satisfaction in acne patients treated with oral isotretinoin. Acta Derm Venereol. 2013;93:701–6.CrossRefGoogle Scholar
  24. 24.
    Ergun T, Seckin D, Ozaydin N, et al. Isotretinoin has no negative effect on attention, executive function and mood. J Eur Acad Dermatol Venereol. 2012;26:431–9.CrossRefGoogle Scholar
  25. 25.
    Bravard P, Krug M, Rzeznick J. Isotretinoin and depression: care is needed. Nouv Dermatol. 1993;12:215.Google Scholar
  26. 26.
    Hull PR, Demkiw-Bartel C. Isotretinoin use in acne: prospective evaluation of adverse events. J Cut Med Surg. 2000;4:66–70.CrossRefGoogle Scholar
  27. 27.
    Bridge JA, Goldstein TR, Brent DA. Adolescent suicide and suicidal behavior. J Child Psychol Psychiatry. 2006;47(3/4):372–94.CrossRefGoogle Scholar
  28. 28.
    Bernal M, Haro JM, Bernert S, et al. Risk factors for suicidality in Europe: results from the ESEMED study. J Affect Disord. 2007;101:27–34.CrossRefGoogle Scholar
  29. 29.
    Magin P, Pond D, Smith W. Isotretinoin, depression and suicide: a review of evidence. Br J Gen Pract. 2005;55:134–8.Google Scholar
  30. 30.
    Sundström A, Alfredsson L, Sjölin-Forsberg G, Gerdén B, Bergman U, Jokinen J. Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study. BMJ. 2010;341:5812.CrossRefGoogle Scholar
  31. 31.
    Krowchuk DP, Stancin T, Keskinen R, et al. The psychosocial effects of acne in adolescents. Pediatr Dermatol. 1991;4:332.CrossRefGoogle Scholar
  32. 32.
    Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol. 1999;140:273–82.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Child and Adolescent PsychiatrySuleyman Demirel University Faculty of MedicineIspartaTurkey
  2. 2.Department of Dermatology, Faculty of MedicineSuleyman Demirel UniversityIspartaTurkey

Personalised recommendations